Kidney Damage in Patients Receiving Cisplatin and Ifosfamide for Solid Tumors
Status:
Suspended
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Studying samples of blood and urine from patients with cancer in the laboratory
may help doctors learn more about changes that occur in DNA and identify biomarkers related
to cancer. It may also help doctors predict how patients will respond to treatment.
PURPOSE: This research study is evaluating kidney damage in patients receiving cisplatin and
ifosfamide for solid tumors.